2024-11-29 02:31:03
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
Corporate/ 2023-07-24
Global Cord Blood Corporation Announced ...

HONG KONG,June 17,2022-- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China\'s leading provider of...

Insilico Medicine appoints Dr. Feng Ren as co-CEO
Health/ 2023-07-22
Insilico Medicine appoints Dr. Feng Ren ...

Dr. Feng Ren,Chief Scientific Officer (CSO) and head of global research and development is named co-CEO of Insilico Medicine

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release